Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protocaine versus dexamethasone plus lidocaine for knee osteoarthritis
IRCT20141023019640N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of dexamethasone and lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain intensity score on the NRS scale and Performance score on the WOMAC scale. Started Feb 2026; status: completed.
02
Drugs
dexamethasonelidocaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20141023019640N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141023019640N6.